Last reviewed · How we verify
NCT03782649
Performance Evaluation of a Novel Non-invasive Glucometer, Calibrated Against Validated Interstitial Glucose References
NA trial testing Working Model 3.4NR in Diabetes Mellitus in 12 participants. Completed in 19 June 2019.
19 June 2019
Quick facts
| Lead sponsor | RSP Systems A/S |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 12 |
| Start date | 29 November 2018 |
| Primary completion | 19 June 2019 |
| Estimated completion | 19 June 2019 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Working Model 3.4NR
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
RSP Systems A/S
Who can join
Adults 18 to 70, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical study has been launched to collect spectral Raman data on the Investigational Medical Device (IMD) compared with reference methods in terms of interstitial fluid samples and capillary and venous references.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03782649
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other RSP Systems A/S trials
Trials by the same sponsor.
- NCT05851469 — Study of a Non-invasive Glucose Measuring Device · NA · completed
- NCT04518813 — A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings · NA · completed
- NCT04060693 — Device Accuracy of Non-invasive Glucose Measurements in Ethnic Skin · NA · withdrawn
- NCT03782441 — Study of a Novel Non-invasive Glucose Monitoring Device · NA · completed
- NCT04033042 — Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions f · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03782649 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RSP Systems A/S
- Last refreshed: 12 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03782649.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing